PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine, Translational Research Center Karolinska (TRACK), Stockholm, Sweden.\', \'Department of Infectious Diseases, Karolinska University Hospital Huddinge, Stockholm, Sweden.\', \'Department of Clinical Genetics, Center for Rare Diseases, Karolinska University Hospital Solna, Stockholm, Sweden.\', \'Dept of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden.\', \'Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.\', \'Department of Laboratory Medicine, Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.\', \'Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.\', \'Broegelmann Laboratory, Department of Clinical Sciences, University of Bergen, Bergen, Norway.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/sji.13153
?:doi
?:hasPublicationType
?:journal
  • Scandinavian journal of immunology
is ?:pmid of
?:pmid
?:pmid
  • 35244285
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.891
?:rankingScore_hIndex
  • 79
is ?:relation_isRelatedTo_publication of
?:title
  • Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID-19 in chronic lymphocytic leukaemia?
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all